CAMBIUM BIO LIMITED — Director's Dealing 2022

Jun 16, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	REGENEUS LIMITED
ABN	13 127 035 358

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	GRAHAM VESEY
Date of last notice	19 November 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Citicorp Nominees Pty Limited as nominee for Graham Vesey
Date of change	10 June 2022
No. of securities held prior to change	15,879,968 fully paid ordinary shares 1,029,500 unlisted options exercisable at $0.14 per share and expiring 31 August 2025
Class	Fully paid ordinary shares Unlisted options
Number acquired	nil
Number disposed	1,108,944 fully paid ordinary shares
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$51,988.78
No. of securities held after change	14,771,042 fully paid ordinary shares 1,029,500 unlisted options

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Off-market transfer of loan funded shares Example: on-market trade, off-market trade, exercise of options, issue in partial repayment of a loan from of securities under dividend reinvestment plan, participation in buyback Regeneus to fund the option exercise price on acquisition of the shares in 2012

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Yes
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes
If prior written clearance was provided, on what date was this provided?	24 February 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011